ASCO-GU Interview | Dr. Junlong Zhuang Interprets the BRCAAway Study and Real-World Genetic Testing in Advanced Prostate Cancer
Editor's Note: In the field of metastatic castration-resistant prostate cancer (mCRPC), the PROfound study marked the beginning of the era of precision targeted therapy for prostate cancer, while the PROpel…